IGF2BP3 and urinary bladder cancer: To evaluate cell proliferation when CDK6 interacted with IGF2BP3 in bladder cancer, we transfected CDK6 small interfering RNA (siCDK6) or control (SCR) into over-expressed IGF2BP3 cells.